{
    "title": "U.S. FDA approves Gilead's long-acting HIV drug Sunlenca",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11566607/U-S-FDA-approves-Gileads-long-acting-HIV-drug-Sunlenca.html",
    "date": "2022-12-22",
    "keywords": [
        "drug",
        "approval",
        "mahobe",
        "administration",
        "therapy",
        "year",
        "treatment",
        "combination",
        "viiv",
        "sunlenca",
        "analyst",
        "dec",
        "food",
        "fda",
        "thursday",
        "way",
        "dosing",
        "injection",
        "company",
        "hiv",
        "replication",
        "virus",
        "chemical",
        "name",
        "healthcare",
        "majority",
        "plc",
        "cabenuva",
        "interval",
        "gilead",
        "addition",
        "vice",
        "president",
        "development",
        "interview",
        "class",
        "capsid",
        "inhibitor",
        "hiv1",
        "midtolatestage",
        "study",
        "lenacapavir",
        "load",
        "end",
        "portfolio",
        "revenue",
        "note",
        "october",
        "peak",
        "reporting",
        "khushi",
        "mandowara",
        "raghav",
        "leo",
        "bengaluru",
        "editing",
        "kalluvila",
        "syamnath"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}